Psoriasis and Pyelonephritis acute
Summary:
Pyelonephritis acute is found among people with Psoriasis, especially for people who are female, 60+ old.
The study analyzes which people have Pyelonephritis acute with Psoriasis. It is created by eHealthMe based on reports of 42 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,477 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.
What is Pyelonephritis acute?
Pyelonephritis acute (sudden inflammation of kidney caused by bacteria) is found to be associated with 364 drugs and 471 conditions by eHealthMe. Check the latest studies of Pyelonephritis acute.
42 people who have Psoriasis and Pyelonephritis Acute are studied.

Gender of people who have Psoriasis and experienced Pyelonephritis Acute *:
- female: 61.29 %
- male: 38.71 %
Age of people who have Psoriasis and experienced Pyelonephritis Acute *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 10.71 %
- 30-39: 3.5700000000000003 %
- 40-49: 25.0 %
- 50-59: 28.57 %
- 60+: 32.14 %
Common co-existing conditions for these people *:
- Urinary Tract Infection: 2 people, 4.76%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 4.76%
- Necrobiosis Lipoidica Diabeticorum (a necrotizing skin condition that usually occurs in patients with diabetes): 2 people, 4.76%
- Sle Arthritis (an autoimmune disease that causes your immune system to attack your body's own joints): 1 person, 2.38%
- Gastric Ulcer (stomach ulcer): 1 person, 2.38%
- Escherichia Sepsis (bacterial infection by escherichia coli): 1 person, 2.38%
- Dyspnea (difficult or laboured breathing): 1 person, 2.38%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 2.38%
Common drugs taken by these people *:
- Stelara: 14 people, 33.33%
- Humira: 9 people, 21.43%
- Cosentyx: 5 people, 11.90%
- Tremfya: 4 people, 9.52%
- Enbrel: 3 people, 7.14%
- Simponi: 3 people, 7.14%
- Pantoprazole: 3 people, 7.14%
- Taltz: 2 people, 4.76%
- Remicade: 2 people, 4.76%
- Cimzia: 2 people, 4.76%
Common symptoms for these people *:
- Pneumonia: 11 people, 26.19%
- Prostate Cancer: 10 people, 23.81%
- Neoplasm Malignant (cancer tumour): 10 people, 23.81%
- Pancreatitis Acute (sudden inflammation of pancreas): 10 people, 23.81%
- Drug Ineffective: 10 people, 23.81%
- Herpes Zoster: 10 people, 23.81%
- Sepsis (a severe blood infection that can lead to organ failure and death): 9 people, 21.43%
- Appendicitis (inflammation of the appendix): 9 people, 21.43%
- Cardiac Failure Congestive: 9 people, 21.43%
- Escherichia Sepsis (bacterial infection by escherichia coli): 9 people, 21.43%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Pyelonephritis acute?
- Check whether Pyelonephritis acute is associated with a drug or a conditionRelated publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Psoriasis (508,163 reports)
- Pyelonephritis acute (2,995 reports)
All the drugs that are associated with Pyelonephritis acute:
- Pyelonephritis acute (364 drugs)
All the conditions that are associated with Pyelonephritis acute:
- Pyelonephritis acute (471 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Pyelonephritis acute and Psoriasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Skelaxin cause Eye Swelling? - 3 seconds ago
- Could Nortriptyline Hydrochloride cause Muscle Aches? - 13 seconds ago
- Drug interactions of Montelukast Sodium and Ketorolac Tromethamine - 15 seconds ago
- Could Pepcid Complete cause Joint Pain? - 20 seconds ago
- Could Fluticasone Propionate cause Vulvovaginal Dryness? - 20 seconds ago
- Could Amoxicillin cause Vascular Pseudoaneurysm? - 21 seconds ago
- Drug interactions of Fluoxetine and Procardia Xl - 22 seconds ago
- Could Flovent cause Protein - Urine? - 37 seconds ago
- Could Loraz cause Bronchospasm Aggravated? - 42 seconds ago
- Could Idhifa cause Memory Loss? - 53 seconds ago